CAPR Stock Rallies Into FDA Decision Month: Retail Spots Approval ‘Tea Leaves’ In Capricor’s Launch Team Hiring
Capricor is recruiting two commercial bosses, with both listings for the preparations for a potential Deramiocel launch. The FDA’s target decision date is Nov.22, following a three-month extension to review additional data. The revised application focuses on preserving arm and hand function in patients with Duchenne muscular dystrophy. A July advisory panel voted 9-3 against … Read more